Section 174 R&D Amortization Calculator (2025–2026 Updated)
AKCalc — Section 174 R&D Amortization Calculator
akcalc.online/section-174-rd-amortization-calculator/ | Generated:
What Section 174 Actually Cost a Company With $1 Million in R&D (2022–2026)
Companies incurring $1 million in domestic SRE during the 2022 tax year were hit with a mandatory 90% deferral of their first-year deduction under original TCJA constraints. As of 2025, firms now face a critical recovery moment to resolve this legacy basis through immediate cost acceleration or continued amortization paths. Use our Texas Paycheck Calculator to see how your take-home pay is affected after R&D deductions reduce your taxable business income.
| Year | Annual Deduction | Cumulative | Balance |
|---|---|---|---|
| 2022 | $100,000 | $100,000 | $900,000 |
| 2023 | $200,000 | $300,000 | $700,000 |
| 2024 | $200,000 | $500,000 | $500,000 |
| 2025 (Full Accel) | $500,000 | $1,000,000 | $0 |
| 2025 (Split Path) | $250,000 | $750,000 | $250,000 |
| 2025 (Status Quo) | $200,000 | $700,000 | $300,000 |
| 2026 (Status Quo) | $100,000 | $800,000 | $200,000 |
| Method | 2025 Deduction | 2025 Savings | 2026 Deduction | 2026 Savings |
|---|---|---|---|---|
| Full Acceleration | $500,000 | $105,000 | $0 | $0 |
| Two-Year Split | $250,000 | $52,500 | $250,000 | $52,500 |
How the TCJA Turned a 70-Year Tax Benefit Into a Cash Flow Crisis
Enacted in 1954, Internal Revenue Code Section 174 functioned as a foundational bet on American innovation by allowing companies to deduct 100% of Specified Research or Experimental (SRE) expenditures in the year they occurred. Scientific advancement and corporate growth remained inextricably linked through this immediate expensing provision until recent legislative shifts dismantled the long-standing baseline.
Tax years beginning after December 31, 2021, forced a dramatic pivot. The Tax Cuts and Jobs Act (TCJA) introduced mandatory capitalization requirements, requiring domestic SRE to be amortized over five years and foreign research over fifteen years. Half-year convention rules meant a company spending $1 million on internal engineering teams in 2022 could claim only a $100,000 deduction that year, turning $900,000 of cash-out-the-door expenses into a deferred tax liability.
Section 174A: What the OBBBA Actually Changed
Section 174A arrived as the legislative successor to the TCJA-era R&D rules, taking effect for domestic expenditures incurred after December 31, 2024. Default tax treatment now allows for immediate 100% expensing of SRE costs, effectively removing the punitive half-year convention for local research. One Big Beautiful Bill Act (OBBBA), signed July 4, 2025, restored this essential provision.
Foreign research and development expenses remain subject to the mandatory 15-year capitalization schedule despite the relief provided to domestic teams. US companies employing offshore engineering talent in Eastern Europe, India, or South America still capitalize those costs over a fifteen-year period. Self-employed consultants and freelancers with qualifying R&D expenditures should also review the Self-Employed Tax Calculator to model the full interaction between deductions and their net tax bill.
The $500,000 Question: Recovering 2022–2024 Legacy Costs
Determining your "legacy basis" serves as the mandatory first step for any firm carrying unamortized R&D costs into the current tax cycle. Revenue Procedure 2025-28 provides the governing authority for resolving these historical capital assets. Innovators currently choose between three distinct recovery paths to resolve their legacy R&D balances.
Section 174 vs. Section 41: Two Different Rules, One R&D Dollar
Section 174 governs timing — when R&D costs are deducted. Section 41 governs eligibility for a dollar-for-dollar credit against tax owed. Every dollar of qualifying R&D is subject to Section 174 amortization rules regardless of whether a credit is claimed. The two sections operate independently. Claiming the Section 41 credit does not exempt costs from Section 174 capitalization requirements.
Under the default coordination rule, the Section 174A deduction is reduced by the full dollar amount of any Section 41 credit claimed. A company taking a $200,000 credit loses $200,000 of deduction — costing $42,000 in additional tax at the 21% rate. The alternative: make a Section 280C(c) election to take a reduced credit at 79% of the gross credit while keeping the full SRE deduction. Formula: Adjusted Credit = Gross Credit × 0.79.
At a 21% corporate rate, both approaches produce identical net outcomes. Below 21% effective rate, the default rule (reduce deduction) wins. Above 21% effective rate, the 280C(c) election wins. Run both scenarios before filing — the difference compounds over multiple years of R&D spending.
The Hidden Tax Trap: How Section 174A Expensing Can Trigger a 163(j) Interest Problem
Section 163(j) limits the business interest deduction to 30% of Adjusted Taxable Income (ATI). When Section 174A immediate expensing pulls large R&D amounts out of ATI, it deflates the base against which interest deductions are measured. For a company with $5 million in annual R&D spend and $3 million in debt interest, switching from TCJA amortization to 174A expensing could reduce ATI by $4.5 million — dropping it below the 163(j) floor and disallowing hundreds of thousands in interest deductions.
Under TCJA 2022–2024 mandatory amortization, the non-deducted SRE portion was added back to ATI, which paradoxically allowed leveraged companies to deduct more interest. Section 174A reverses this. Every dollar of additional R&D deduction can reduce 163(j) capacity by $0.30 at the margin. Companies with a debt-to-EBITDA ratio above 3x and significant domestic R&D must model both scenarios before filing.
The Section 174A(b) 60-month election exists precisely for this situation. Electing amortization rather than immediate expensing preserves higher ATI and protects the interest deduction. Consulting a CPA before making the 174A election is not optional for leveraged companies.
The GILTI Shadow Tax: How Foreign R&D Capitalization Creates a Hidden International Liability
Global Intangible Low-Taxed Income (GILTI) is a minimum tax on earnings of foreign subsidiaries of US multinationals. Foreign R&D costs capitalized over 15 years under Section 174 are not deducted at the subsidiary level in full — they sit on the balance sheet as an amortizing asset. The foreign subsidiary's tested income is therefore higher than it would be under immediate expensing, which increases the GILTI inclusion on the US parent's return. The mandatory 15-year foreign amortization that survived OBBBA creates a compounding GILTI penalty for US companies with offshore research teams that most R&D tax tools completely ignore.
The GILTI High-Tax Exception (HTE) allows a US parent to exclude GILTI inclusions if the foreign subsidiary's effective tax rate exceeds 18.9% (90% of the 21% US corporate rate). When foreign R&D is not deducted at the subsidiary level due to capitalization, the subsidiary's taxable income appears higher, potentially distorting the effective rate calculation and causing loss of the HTE exclusion — even for subsidiaries in high-tax jurisdictions like Germany.
Multinationals with foreign R&D spend above $500,000 annually should run a GILTI model that inputs capitalized vs. expensed R&D scenarios at the tested-income level before filing. The 15-year foreign amortization is not optional, but the GILTI interaction can be managed through foreign tax credit stacking rules and tested loss netting across subsidiaries.
The Decoupling Problem: Federal vs. State Compliance
Section 174A is a federal provision, yet states maintain independent control. Many jurisdictions have decoupled—meaning the OBBBA restoration does NOT apply for state income tax purposes. A company in California gets the full federal deduction in 2025 but still capitalizes the same costs over 5 years for California franchise tax, creating a mandatory "dual-ledger" compliance requirement.
| State | 2025–2026 Conformity Status | Notes |
|---|---|---|
| California | Decoupled | Does not conform to TCJA amortization OR Section 174A. Immediate expensing allowed for state purposes under pre-TCJA rules. |
| Pennsylvania | Decoupled | No R&D expensing conformity. State tax rules remain independent of federal 174/174A changes. |
| Illinois | Decoupled | Static conformity — fixed to pre-TCJA code. Section 174A not adopted. |
| Michigan | Decoupled | Does not adopt Section 174A for 2025–2026. |
| Virginia | Paused Conformity | Rolling conformity paused until 2027. Taxpayers follow pre-OBBBA rules for state purposes. Verify with Virginia Tax before filing. |
| Maryland | Decoupled 2025 | Decoupled for 2025. Potential conformity in 2026 pending legislative session. Verify current status with Maryland Comptroller. |
| Alabama | Decoupled | Static conformity — Section 174A not reflected in state code. |
| Delaware | Decoupled | Static conformity. No adoption of OBBBA changes. |
| New York | Conforms | Follows federal 174A treatment for 2025+ tax years. |
| Texas | No Corporate Income Tax | N/A — no state income tax impact. |
| Florida | No Corporate Income Tax | N/A — no state income tax impact. |
State-level conformity rules often lag behind federal legislative changes. Decoupled states do not recognize the immediate 100% deduction restored by Section 174A. The result: taxpayers must maintain separate amortization schedules for federal and state returns. Planning for these complexities is essential because filing errors often occur when modeling is not performed using professional R&D software.
SaaS and Software Companies: Qualifying Costs
Software development costs fall under Section 174 ONLY during specific phases. IRS Notice 2023-63 defines the boundary. The "Technological Feasibility" threshold determines when Section 174 treatment ends and Section 162 immediate deduction begins. Costs incurred after a working model or master is produced for sold software, or after the "application development stage" ends for internal software, are NOT Section 174.
Section 174 R&D Amortization: The Questions Tax Teams Are Actually Asking in 2026
Calculation Methodology & Data Sources
Every calculation on this page uses IRS-published statutory rates and Revenue Procedures current as of the 2026 filing season. Corporate tax rate: 21% per IRC Section 11(b).
TCJA Amortization (2022–2024)
Domestic: Year 1 = 10% (half-year convention), Years 2–5 = 20%, Year 6 = 10%. Total: 100% over 6 years. Foreign: Amortized precisely over 15 years using exact half-year convention division (SRE ÷ 15). Year 1 = half-year amount, Years 2–15 = full annual amount, Year 16 = half-year amount. Total lifetime foreign deduction equals exactly 100.00% of original SRE. Basis: IRS Notice 2023-63.
Section 174A Restoration (2025+)
Restores 100% immediate expensing for domestic SRE. Elective 60-month amortization follows the 10/20/20/20/20/10 schedule. Foreign costs remain on the 15-year TCJA path per Rev Proc 2025-28.
Legacy Recovery (Rev Proc 2025-28)
Full Acceleration: 100% of legacy basis deducted in 2025. Two-Year Split: 50% in 2025, 50% in 2026. Status Quo: Continues original 5-year amortization without catch-up.
Section 174A Elective 60-Month Amortization
Taxpayers who elect 60-month amortization under Section 174A(b) use the same half-year convention schedule as TCJA domestic: Year 1 = 10%, Years 2–5 = 20%, Year 6 = 10%. The election is made on the return for the year the expenditure is incurred. Once made, the election applies to all SRE incurred in that year and cannot be revoked without IRS consent. Source: IRC Section 174A(b), One Big Beautiful Bill Act (OBBBA), enacted July 4, 2025.
Section 280C(c) Credit Coordination
Default rule: reduce Section 174A deduction by the dollar amount of Section 41 credit claimed. Section 280C(c) election: take reduced credit at Gross Credit × 0.79 (100% minus 21% corporate rate), preserve full deduction. Corporate tax rate used throughout: 21% per IRC Section 11(b). Users who input a custom rate override this default in all calculations.